The Prevalence of Simultaneously Ordering Amylase and Lipase for Diagnosing Pancreatitis.

IF 1.2 4区 医学 Q3 EMERGENCY MEDICINE
Emergency Medicine International Pub Date : 2023-09-27 eCollection Date: 2023-01-01 DOI:10.1155/2023/3988278
Bader Alyahya, Abdulaziz Alalshaikh, Abdulaziz Altaweel, Gadah Alsaleh, Abdullah Alsaeed, Haneen Somily, Taif Alotaibi, Mohammed Alaqeel, Abdulaziz Al Mehlisi, Fahad Abuguyan, Fawaz Altuwaijri, Zohair Al Aseri
{"title":"The Prevalence of Simultaneously Ordering Amylase and Lipase for Diagnosing Pancreatitis.","authors":"Bader Alyahya,&nbsp;Abdulaziz Alalshaikh,&nbsp;Abdulaziz Altaweel,&nbsp;Gadah Alsaleh,&nbsp;Abdullah Alsaeed,&nbsp;Haneen Somily,&nbsp;Taif Alotaibi,&nbsp;Mohammed Alaqeel,&nbsp;Abdulaziz Al Mehlisi,&nbsp;Fahad Abuguyan,&nbsp;Fawaz Altuwaijri,&nbsp;Zohair Al Aseri","doi":"10.1155/2023/3988278","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The simultaneous measurement of serum amylase and lipase levels in the diagnosis of pancreatitis was deemed unnecessary in several studies. We aim at evaluating the prevalence of the simultaneous co-ordering of serum amylase and lipase.</p><p><strong>Methods: </strong>This retrospective chart review was conducted at King Saud University Medical City in Riyadh, Saudi Arabia, between January 2021 and January 2022. We examined requests for serum amylase or serum lipase levels that had been sought for suspected pancreatitis within the electronic health system (EHS).</p><p><strong>Results: </strong>A total of 9,617 requests for serum amylase and serum lipase levels for 5,536 patients were made in a year; 6,873 (71.5%) were made for serum lipase alone; 1,672 (17.4%) were made for co-ordered serum lipase and amylase; 322 (3.3%) were made for amylase alone; and 750 (7.8%) were made for repeated amylase testing. Four hundred and thirteen tests (4.3%) yielded a diagnosis of pancreatitis. The estimated cost reduction when serum amylase was removed if serum lipase was co-ordered was 108,680 SAR (approximately US$28,960).</p><p><strong>Conclusion: </strong>Serum amylase and lipase were co-ordered for about 17.4% of pancreatitis diagnostic tests, all of which were unnecessary. Eliminating serum amylase testing for any patient who receives a test of their lipase levels would exert a significant impact on institutional costs and savings.</p>","PeriodicalId":11528,"journal":{"name":"Emergency Medicine International","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551519/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emergency Medicine International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/3988278","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The simultaneous measurement of serum amylase and lipase levels in the diagnosis of pancreatitis was deemed unnecessary in several studies. We aim at evaluating the prevalence of the simultaneous co-ordering of serum amylase and lipase.

Methods: This retrospective chart review was conducted at King Saud University Medical City in Riyadh, Saudi Arabia, between January 2021 and January 2022. We examined requests for serum amylase or serum lipase levels that had been sought for suspected pancreatitis within the electronic health system (EHS).

Results: A total of 9,617 requests for serum amylase and serum lipase levels for 5,536 patients were made in a year; 6,873 (71.5%) were made for serum lipase alone; 1,672 (17.4%) were made for co-ordered serum lipase and amylase; 322 (3.3%) were made for amylase alone; and 750 (7.8%) were made for repeated amylase testing. Four hundred and thirteen tests (4.3%) yielded a diagnosis of pancreatitis. The estimated cost reduction when serum amylase was removed if serum lipase was co-ordered was 108,680 SAR (approximately US$28,960).

Conclusion: Serum amylase and lipase were co-ordered for about 17.4% of pancreatitis diagnostic tests, all of which were unnecessary. Eliminating serum amylase testing for any patient who receives a test of their lipase levels would exert a significant impact on institutional costs and savings.

Abstract Image

Abstract Image

同时订购淀粉酶和脂肪酶诊断胰腺炎的患病率。
背景:几项研究认为,在诊断胰腺炎时同时测量血清淀粉酶和脂肪酶水平是不必要的。我们的目的是评估血清淀粉酶和脂肪酶同时共序的患病率。方法:本回顾性图表回顾于2021年1月至2022年1月在沙特阿拉伯利雅得沙特国王大学医学城进行。我们检查了在电子健康系统(EHS)中为疑似胰腺炎寻求的血清淀粉酶或血清脂肪酶水平的请求。结果:一年内,5536名患者共提出9617项血清淀粉酶和血清脂肪酶水平请求;血清脂肪酶单独作用6873个(71.5%);血清脂肪酶和淀粉酶共有1672个(17.4%);322个(3.3%)单独用于淀粉酶;750个(7.8%)用于重复淀粉酶测试。413次检查(4.3%)诊断为胰腺炎。如果联合订购血清脂肪酶,去除血清淀粉酶的估计成本降低为108680 SAR(约28960美元)。结论:约17.4%的胰腺炎诊断测试联合订购血清淀粉酶和脂肪酶,所有这些都是不必要的。取消任何接受脂肪酶水平测试的患者的血清淀粉酶测试将对机构成本和节省产生重大影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Emergency Medicine International
Emergency Medicine International EMERGENCY MEDICINE-
CiteScore
0.10
自引率
0.00%
发文量
187
审稿时长
17 weeks
期刊介绍: Emergency Medicine International is a peer-reviewed, Open Access journal that provides a forum for doctors, nurses, paramedics and ambulance staff. The journal publishes original research articles, review articles, and clinical studies related to prehospital care, disaster preparedness and response, acute medical and paediatric emergencies, critical care, sports medicine, wound care, and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信